Beta

Mainz biomed n.v.QUCY.US Overview

US StockHealthcare
(No presentation for QUCY)
OverviewAI AnalysisFinancialsFinancial ForecastStock SentimentalTradingView Chart

Ticker

Value

empty

There is no following symbol in this watchlist.

QUCY AI Insights

QUCY Overall Performance

QUCY AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

QUCY Recent Performance

-7.04%

Mainz biomed n.v.

-1.10%

Avg of Sector

-0.49%

S&P500

QUCY PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

Check QUCY's Trend

QUCY Key Information

QUCY Valuation Metrics

QUCY Profile

Price of QUCY

QUCY FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

QUCY Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
11.83
PB Ratio
9.90
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
-%
Net Margin
-%
Revenue Growth (YoY)
-%
Profit Growth (YoY)
-%
3-Year Revenue Growth
-%
3-Year Profit Growth
-%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
11.83
PB Ratio
9.90
Price-to-FCF
-
Gross Margin
-%
Net Margin
-%
Revenue Growth (YoY)
-%
Profit Growth (YoY)
-%
3-Year Revenue Growth
-%
3-Year Profit Growth
-%

  • When is QUCY's latest earnings report released?

    The most recent financial report for Mainz biomed n.v. (QUCY) covers the period of 2025Q4 and was published on 2025/12/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating QUCY's short-term business performance and financial health. For the latest updates on QUCY's earnings releases, visit this page regularly.

  • How much debt does QUCY have?

    As of the end of the reporting period, Mainz biomed n.v. (QUCY) had total debt of 2.57M, with a debt ratio of 0.48. Short-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.

  • How much cash does QUCY have?

    At the end of the period, Mainz biomed n.v. (QUCY) held Total Cash and Cash Equivalents of 889.09K, accounting for 0.17 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.